Fed. Circ. Tosses 'Unusual' Appeal On Menopause Drug IP
The Federal Circuit on Tuesday dismissed an "unusual" appeal from drugmaker Sebela Ireland Ltd., which sought affirmation of a district court decision that claims in two patents covering its menopause drug...To view the full article, register now.
Already a subscriber? Click here to view full article